4.0 Article

Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate

Related references

Note: Only part of the references are listed.
Article Pathology

Increased expression levels of integrin αvβ5 on scleroderma fibroblasts

Y Asano et al.

AMERICAN JOURNAL OF PATHOLOGY (2004)